Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kofler, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bernhard, D; Skvortsov, S; Tinhofer, I; Hubl, H; Greil, R; Csordas, A; Kofler, R
      Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts

      CELL DEATH AND DIFFERENTIATION
    2. Obexer, P; Certa, U; Kofler, R; Helmberg, A
      Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis

      ONCOGENE
    3. Tonko, M; Ausserlechner, MJ; Bernhard, D; Helmberg, A; Kofler, R
      Gene expression profiles of proliferating vs. G1/G0 arrested human leukemia cells suggest a mechanism for glucocorticoid-induced apoptosis

      FASEB JOURNAL
    4. Ruefli, AA; Ausserlechner, MJ; Bernhard, D; Sutton, VR; Tainton, KM; Kofler, R; Smyth, MJ; Johnstone, RW
      The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    5. Mandl, CW; Kroschewski, H; Allison, SL; Kofler, R; Holzmann, H; Meixner, T; Heinz, FX
      Adaptation of tick-borne encephalitis virus to BHK-21 cells results in theformation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo

      JOURNAL OF VIROLOGY
    6. Ausserlechner, MJ; Obexer, P; Wiegers, GJ; Hartmann, BL; Geley, S; Kofler, R
      The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels (vol 276, pg 10984, 2001)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Ausserlechner, MJ; Obexer, P; Wiegers, GJ; Hartmann, BL; Geley, S; Kofler, R
      The cell cycle inhibitor p16(INK4A) sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels

      JOURNAL OF BIOLOGICAL CHEMISTRY
    8. Tiefenthaler, M; Amberger, A; Bacher, N; Hartmann, BL; Margreiter, R; Kofler, R; Konwalinka, G
      Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cells

      BRITISH JOURNAL OF HAEMATOLOGY
    9. Pallis, M; Grundy, M; Turzanski, J; Kofler, R; Russell, N
      Mitochondrial membrane sensitivity to depolarization in acute myeloblasticleukemia is associated with spontaneous in vitro apoptosis, wild-type TP53, and vicinal thiol/disulfide status

      BLOOD
    10. Bernhard, D; Tinhofer, I; Tonko, M; Hubl, H; Ausserlechner, MJ; Greil, R; Kofler, R; Csordas, A
      Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells

      CELL DEATH AND DIFFERENTIATION
    11. Kofler, R
      The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells

      HISTOCHEMISTRY AND CELL BIOLOGY
    12. Bernhard, D; Loffler, M; Hartmann, BL; Yoshida, M; Kofler, R; Csordas, A
      Interaction between dexamethasone and butyrate in apoptosis induction: non-additive in thymocytes and synergistic in a T cell-derived leukemia cell line

      CELL DEATH AND DIFFERENTIATION
    13. Loffler, M; Ausserlechner, MJ; Tonko, M; Hartmann, BL; Bernhard, D; Geley, S; Helmberg, A; Kofler, R
      c-Myc does not prevent glucocorticoid-induced apoptosis of human leukemic lymphoblasts

      ONCOGENE
    14. Hartmann, BL; Geley, S; Loffler, M; Hattmannstorfer, R; Strasser-Wozak, EMC; Auer, B; Kofler, R
      Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis

      ONCOGENE
    15. Bernhard, D; Ausserlechner, MJ; Tonko, M; Loffler, M; Hartmann, BL; Csordas, A; Kofler, R
      Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts

      FASEB JOURNAL
    16. Kuhr, T; Bechter, O; Geley, S; Eisterer, W; Lukas, P; Url, M; Dietrich, H; Hilbe, W; Kofler, R; Thaler, J
      Detection and quantitation of genetically marked acute myeloid leukemia bycompetitive polymerase chain reaction after autologous bone marrow transplantation: A preclinical model for minimal residual disease

      EXPERIMENTAL HEMATOLOGY
    17. Hartmann, BL; Geley, S; Kofler, R
      Sequence-specific transcription factors during glucocorticoid-induced apoptosis in acute lymphoblastic leukemia cells

      WIENER KLINISCHE WOCHENSCHRIFT
    18. STRASSERWOZAK EMC; HARTMANN BL; GELEY S; SGONC R; BOCK G; DOSSANTOS AJO; HATTMANNSTORFER R; WOLF H; PAVELKA M; KOFLER R
      IRRADIATION INDUCES G2 M CELL-CYCLE ARREST AND APOPTOSIS IN P53-DEFICIENT LYMPHOBLASTIC-LEUKEMIA CELLS WITHOUT AFFECTING BCL-2 AND BAX EXPRESSION/

      Cell death and differentiation
    19. ZAMZAMI N; MARZO I; SUSIN SA; BRENNER C; LAROCHETTE N; MARCHETTI P; REED J; KOFLER R; KROEMER G
      THE THIOL CROSS-LINKING AGENT DIAMIDE OVERCOMES THE APOPTOSIS-INHIBITORY EFFECT OF BCL-2 BY ENFORCING MITOCHONDRIAL PERMEABILITY TRANSITION

      Oncogene
    20. PEHAMBERGER H; SOYER HP; STEINER A; KOFLER R; BINDER M; MISCHER P; PACHINGER W; AUBOCK J; FRITSCH P; KERL H; WOLFF K
      ADJUVANT INTERFERON ALPHA-2A TREATMENT IN RESECTED PRIMARY STAGE-II CUTANEOUS MELANOMA

      Journal of clinical oncology
    21. CSORDAS A; BERNHARD D; LOFFLER M; KOFLER R
      INTERFERENCE OF BUTYRATE WITH DEXAMETHASONE-INDUCED APOPTOSIS IN THYMOCYTES AND LEUKEMIC LYMPHOBLASTS

      Molecular biology of the cell
    22. JOEHRER K; GELEY S; STRASSERWOZAK EMC; AZZIZ R; WOLLMANN HA; SCHMITT K; KOFLER R; WHITE PC
      CYP11B1 MUTATIONS CAUSING NONCLASSIC ADRENAL-HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY

      Human molecular genetics
    23. GELEY S; HARTMANN BL; HATTMANNSTORFER R; LOFFLER M; AUSSERLECHNER MJ; BERNHARD D; SGONC R; STRASSERWOZAK EMC; EBNER M; AUER B; KOFLER R
      P53-INDUCED APOPTOSIS IN THE HUMAN T-ALL CELL-LINE CCRF-CEM

      Oncogene
    24. GELEY S; HARTMANN BL; KAPELARI K; EGLE A; VILLUNGER A; HEIDACHER D; GREIL R; AUER B; KOFLER R
      THE INTERLEUKIN 1-BETA-CONVERTING ENZYME-INHIBITOR CRMA PREVENTS APO1FAS-INDUCED BUT NOT GLUCOCORTICOID-INDUCED POLY(ADP-RIBOSE) POLYMERASE CLEAVAGE AND APOPTOSIS IN LYMPHOBLASTIC-LEUKEMIA CELLS/

      FEBS letters
    25. GELEY S; HARTMANN BL; KOFLER R
      CERAMIDES INDUCE A FORM OF APOPTOSIS IN HUMAN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS THAT IS INHIBITED BY BCL-2, BUT NOT BY CRMA

      FEBS letters
    26. VILLUNGER A; EGLE A; KOS M; HARTMANN BL; GELEY S; KOFLER R; GREIL R
      DRUG-INDUCED APOPTOSIS IS ASSOCIATED WITH ENHANCED FAS (APO-1 CD95) LIGAND EXPRESSION BUT OCCURS INDEPENDENTLY OF FAS (APO-1/CD95) SIGNALING IN HUMAN T-ACUTE LYMPHATIC-LEUKEMIA CELLS/

      Cancer research
    27. DECAUDIN D; GELEY S; HIRSCH T; CASTEDO M; MARCHETTI P; MACHO A; KOFLER R; KROEMER G
      BCL-2 AND BCL-X(L) ANTAGONIZE THE MITOCHONDRIAL DYSFUNCTION PRECEDINGNUCLEAR APOPTOSIS INDUCED BY CHEMOTHERAPEUTIC-AGENTS

      Cancer research
    28. GREIL R; VILLUNGER A; EGLE A; MARSCHITZ L; KOS M; BOCK G; LUDWIG H; GELEY S; KOFLER R
      FAS (APO-1 CD95) - LIGAND EXPRESSION ON NEOPLASTIC PLASMA-CELLS AND ITS ROLE FOR THE EXPANSION OF THE NEOPLASTIC CLONE/

      Blood
    29. VILLUNGER A; EGLE A; MARSCHITZ I; KOS M; BOCK G; LUDWIG H; GELEY S; KOFLER R; GREIL R
      CONSTITUTIVE EXPRESSION OF FAS (APO-1 CD95) LIGAND ON MULTIPLE-MYELOMA CELLS - A POTENTIAL MECHANISM OF TUMOR-INDUCED SUPPRESSION OF IMMUNESURVEILLANCE/

      Blood
    30. KALINKE U; BUCHER EM; ERNST B; OXENIUS A; ROOST HP; GELEY S; KOFLER R; ZINKERNAGEL RM; HENGARTNER H
      THE ROLE OF SOMATIC MUTATION IN THE GENERATION OF THE PROTECTIVE HUMORAL IMMUNE-RESPONSE AGAINST VESICULAR STOMATITIS-VIRUS

      Immunity
    31. KOFLER H; AICHBERGER S; OTT G; CASARI A; KOFLER R
      LACK OF ASSOCIATION BETWEEN ATOPY AND THE ILE181LEU VARIANT OF THE BETA-SUBUNIT OF THE HIGH-AFFINITY IMMUNOGLOBULIN-E RECEPTOR

      International archives of allergy and immunology
    32. VIERHAPPER H; VIERHAPPER MS; KAPELARI K; BAUMGARTNERPARZER S; KOFLER R
      CONSANGUINITY IN 2 SEEMINGLY UNRELATED PATIENTS WITH CONGENITAL ADRENAL-HYPERPLASIA

      Lancet
    33. GELEY S; KAPELARI K; JOHRER K; PETER M; GLATZL J; VIERHAPPER H; SCHWARZ S; HELMBERG A; SIPPELL WG; WHITE PC; KOFLER R
      CYP11B1 MUTATIONS CAUSING CONGENITAL ADRENAL-HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY

      The Journal of clinical endocrinology and metabolism
    34. HALA M; HARTMANN BL; BOCK G; GELEY S; KOFLER R
      GLUCOCORTICOID-RECEPTOR-GENE DEFECTS AND RESISTANCE TO GLUCOCORTICOID-INDUCED APOPTOSIS IN HUMAN LEUKEMIC-CELL LINES

      International journal of cancer
    35. GELEY S; HARTMANN BL; HALA M; STRASSERWOZAK EMC; KAPELARI K; KOFLER R
      RESISTANCE TO GLUCOCORTICOID-INDUCED APOPTOSIS IN HUMAN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CEM-C1 CELLS IS DUE TO INSUFFICIENT GLUCOCORTICOID RECEPTOR EXPRESSION

      Cancer research
    36. STRASSERWOZAK EMC; HALA M; HARTMANN BL; KAPELARI K; GELEY S; KOFLER R
      RESISTANCE TO GLUCOCORTICOID (GC) INDUCED APOPTOSIS IN HUMAN ACUTE LEUKEMIC-CELL LINES CAUSED BY QUANTITATIVE AND QUALITATIVE DEFECTS IN GC-RECEPTOR EXPRESSION

      Molecular biology of the cell
    37. SMOLLE J; HOFMANNWELLENHOF R; KOFLER R; CERRONI L; HAAS J; KERL H
      COMPUTER-SIMULATIONS OF HISTOLOGIC PATTERNS IN MELANOMA USING A CELLULAR-AUTOMATON PROVIDE CORRELATIONS WITH PROGNOSIS

      Journal of investigative dermatology
    38. GELEY S; JOHRER K; PETER M; DENNER K; BERNHARDT R; SIPPELL WG; KOFLER R
      AMINO-ACID SUBSTITUTION R384P IN ALDOSTERONE SYNTHASE CAUSES CORTICOSTERONE METHYLOXIDASE TYPE-I DEFICIENCY

      The Journal of clinical endocrinology and metabolism
    39. RIEGER E; SOYER HP; GARBE C; BUTTNER P; KOFLER R; WEISS J; STOCKER U; KRUGER S; ROSER M; WECKBECKER J; PANIZZON R; BAHMER F; TILGEN W; KERL H; ORFANOS CE
      OVERALL AND SITE-SPECIFIC RISK OF MALIGNANT-MELANOMA ASSOCIATED WITH NEVUS COUNTS AT DIFFERENT BODY SITES - A MULTICENTER CASE-CONTROL STUDY OF THE GERMAN-CENTRAL-MALIGNANT-MELANOMA-REGISTRY

      International journal of cancer
    40. ZOCHER I; ROSCHENTHALER F; KIRSCHBAUM T; SCHABLE KF; HORLEIN R; FLEISCHMANN B; KOFLER R; GELEY S; HAMEISTER H; ZACHAU HG
      CLUSTERED AND INTERSPERSED GENE FAMILIES IN THE MOUSE IMMUNOGLOBULIN-CHI LOCUS

      European Journal of Immunology
    41. FIEGL M; STRASSERWOZAK E; GELEY S; GSUR A; DRACH J; KOFLER R
      GLUCOCORTICOID-MEDIATED IMMUNOMODULATION - HYDROCORTISONE ENHANCES IMMUNOSUPPRESSIVE ENDOGENOUS RETROVIRAL PROTEIN (P15E) EXPRESSION IN MOUSE IMMUNE CELLS

      Clinical and experimental immunology
    42. STRASSERWOZAK EMC; HATTMANNSTORFER R; HALA M; HARTMANN BL; FIEGL M; GELEY S; KOFLER R
      SPLICE-SITE MUTATION IN THE GLUCOCORTICOID RECEPTOR GENE CAUSES RESISTANCE TO GLUCOCORTICOID-INDUCED APOPTOSIS IN A HUMAN ACUTE LEUKEMIC-CELL LINE

      Cancer research
    43. KALINKE U; BUCHER E; OXENIUS A; GELEY S; KOFLER R; TRAUNECKER A; ZINKERNAGEL RM; HENGARTNER H
      VIRUS NEUTRALIZING ANTIBODIES WITHOUT SOMATIC POINT MUTATION

      Journal of cellular biochemistry
    44. KOFLER R; RIEGER E; SOYER HP; SMOLLE J; KERL H
      LATE METASTASIS FROM CUTANEOUS MALIGNANT- MELANOMA

      Hautarzt
    45. RIEGER E; KOFLER R; BORKENSTEIN M; SCHWINGSHANDL J; SOYER HP; KERL H
      MELANOTIC MACULES FOLLOWING BLASCHLIS LINES IN MCCUNE-ALBRIGHT SYNDROME

      British journal of dermatology
    46. RIEGER E; HOFMANNWELLENHOF R; SOYER HP; KOFLER R; CERRONI L; SMOLLE J; KERL H
      COMPARISON OF PROLIFERATIVE ACTIVITY AS ASSESSED BY PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND KI-67 MONOCLONAL-ANTIBODIES IN MELANOCYTIC SKIN-LESIONS - A QUANTITATIVE IMMUNOHISTOCHEMICAL STUDY

      Journal of cutaneous pathology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 12:34:27